Clinical Trials on Protein Metabolism

Total 59881 results

Organon and Co

Completed

Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

Dyslipidemia
Zeltiq Aesthetics

Completed

Non-invasive Cooling of Subcutaneous Fat

Fat Disorder

United States
TC Erciyes University

Completed

The Effect Of Low-Fat And Low-Cholesterol Dietary Intervention On LDL Sub-Groups In Turkısh Dyslipidemic Patients

Dyslipidemias

Turkey
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Dyslipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

Dyslipidemias

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

Dyslipidemia

Turkey
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. (DISSEMINATE)

Dyslipidemia

Malaysia
AstraZeneca
Parexel

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects

Dyslipidemia

United States
Dominion Aesthetic Technologies, Inc.

Completed

Eon™ FR Clinical Study Protocol 1064

Fat Disorder

United States
Veloxis Pharmaceuticals

Completed

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

Dyslipidemia

United States
Canadian Collaborative Research Network
Valeant Canada Limited

Completed

Colesevelam, Lipids And Sugars, South Asian Canadian Trial (CLASS-ACT)

Dyslipidemia

Canada
Syneron Medical

Completed

SlimShape Device for Abdominal Fat and Circumference Reduction

Fat Disorder

United States
Tufts University

Completed

Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans

Dyslipidemia

United States
Seoul National University Hospital

Unknown

Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

Dyslipidemias
Chong Kun Dang Pharmaceutical

Completed

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Dyslipidemias

Australia
Eli Lilly and Company

Completed

A Study of LY2484595 in Japanese Subjects

Dyslipidemias

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
UNEEG Medical A/S

Completed

Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects

Healthy

Denmark
Mansoura University

Unknown

Vitamin D Supplementation for Treatment of Dyslipidemia

Dyslipidemias

Egypt
Lesaffre International

Completed

Effect of Saccharomyces Cerevisiae in LDL Cholesterol (HONEY)

Dyslipidemias

France
The University of Hong Kong

Completed

The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C

Dyslipidemia

Hong Kong
Northwell Health
Novartis

Completed

Iron Overload in Pediatric Oncology Patients

Iron Overload

United States
Institute for Clinical Effectiveness and Health...

Completed

Statins at the Primary Care Level (EPRINA)

Dyslipidemia

Argentina
GE Healthcare

Completed

Non-invasive Quantification of Liver Iron With MRI

Iron Overload

United States
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Dyslipidemias

Korea, Republic of
University of Leeds

Completed

Effects of Polyphenols Found in Pomegranate Juice on Postprandial Blood Glucose in Vivo

Hyperglycaemia

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)

Dyslipidemia
Vanderbilt University Medical Center

Completed

Identification of Inpatients at Risk for Poor Glycemic Control

Hyperglycemia | Hypoglycemia

United States
Postgraduate Institute of Medical Education and...

Completed

Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy

Dyslipidemias

India
Azienda Ospedaliero-Universitaria di Parma
DOC generici srl

Completed

Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects (Coleosoma)

Dyslipidemias

Italy
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled (ROMANTIC)

Dyslipidemias
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (ENTHRALL)

Dyslipidemias

United States
The Hospital for Sick Children

Completed

Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial

Dyslipidemias
University of Pennsylvania
Abbott

Completed

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study (CENTAUR)

Dyslipidemia

United States
University of Leeds

Completed

Effects of Carbohydrase-inhibiting Polyphenols on Glycaemic Response in Vivo

Hyperglycaemia

United Kingdom
Merck Sharp & Dohme LLC

Completed

Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

Fenofibrate Bioequivalence Study (0767-031)

Dyslipidemia
University of Palermo

Completed

Bergamot and Cardio-Metabolic Risk Factors

Dyslipidemia

Italy
Merck Sharp & Dohme LLC

Completed

A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Dyslipidemia
University of Alberta
AstraZeneca

Completed

A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (RxACT)

Dyslipidemias

Canada
Merck Sharp & Dohme LLC

Completed

A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Dyslipidemia
Merck Sharp & Dohme LLC

Withdrawn

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Dyslipidemia
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
AstraZeneca
Fundació Institut Català de Farmacologia

Withdrawn

Observational Study To Evaluate Statins Patterns Of Use In Spain

Dyslipidemia

Spain
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States

3

Subscribe